Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)

Clinical trial NCT07740512 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07740512
Sponsor: Polaryx Therapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lysosomal Storage Disorders Sandhoff Disease Krabbe Disease CLN2 CLN3

Start date: 2026-12-01
Primary completion: 2028-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.